Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.2K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

27
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
27
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

32
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
32
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

37
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
37
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Age and sex specific coronary plaque characteristics among South Asians: Insights from the DILWALE CTA study.

American journal of preventive cardiology·2026
Same authorSame journal

Beyond LDL-C: Triangulating residual risk via lipoprotein(a), remnant cholesterol, and vascular inflammation.

Progress in cardiovascular diseases·2026
Same author

Primary Prevention of Dyslipidemia: 10 Practice-Changing Takeaways from the 2026 ACC/AHA Multisociety Guideline.

Current atherosclerosis reports·2026
Same author

Highlights of Cardiovascular Disease Prevention Studies Presented at the 2026 American College of Cardiology Conference.

Current atherosclerosis reports·2026
Same author

Diagnostic Performance of Two CCTA Derived Noninvasive FFR Techniques: The TripleFFR Study.

Circulation. Cardiovascular imaging·2026
Same author

Global Burden of Cardiovascular Disease: What Should Be Expected in the Next 25 Years?

Current cardiology reports·2026

相关实验视频

Updated: Sep 10, 2025

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
09:11

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Published on: September 22, 2014

12.1K

对心力衰竭的细胞疗法 - - 最近的进展和未来的发展方向

Roberto Bolli1, Joshua M Hare2, Emerson C Perin3

  • 1Division of Cardiology, University of Louisville, Louisville, KY, United States of America.

Progress in cardiovascular diseases
|August 27, 2025
PubMed
概括

细胞治疗对治疗心力衰竭 (HF) 是有前途的,中细胞 (MSC) 在临床试验中显示出安全性和潜在益处. 需要进一步的大规模研究来证实疗效,并确定细胞治疗是可行的HF治疗选择.

关键词:
干细胞心脏再生心脏的修复心脏衰竭

更多相关视频

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart
11:45

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

6.7K
Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment
08:24

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Published on: May 25, 2020

7.0K

相关实验视频

Last Updated: Sep 10, 2025

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
09:11

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Published on: September 22, 2014

12.1K
Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart
11:45

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

6.7K
Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment
08:24

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Published on: May 25, 2020

7.0K

科学领域:

  • 复原医学
  • 心脏病学
  • 细胞生物学

背景情况:

  • 全球心力衰竭 (HF) 患病率正在上升,这对公众健康构成重大挑战.
  • 目前的治疗方法有局限性,需要新的治疗策略.
  • 细胞疗法已成为改善HF结果的有希望的方法.

研究的目的:

  • 审查心力衰竭细胞治疗的进展和未来方向.
  • 总结各种细胞类型在HF治疗中的安全性和有效性数据.
  • 探索用于增强HF治疗的新细胞类型和输送策略.

主要方法:

  • 对HF细胞治疗的现有文献的审查.
  • 来自众多研究和随机对照试验的安全数据的分析.
  • 使用介质细胞 (MSC) 的临床结果的评估.

主要成果:

  • 细胞治疗,特别是MSCs,在HF患者中显示出强烈的安全性.
  • 一些试验表明细胞治疗对心肌病的临床结果有好处.
  • 目前正在进行的试验正在研究新的细胞类型和输送方法,如重复剂量和静脉输送.

结论:

  • 细胞疗法作为未来心力衰竭治疗的重要潜力.
  • 强有力的安全数据和有前途的疗效信号需要进一步的大规模临床试验.
  • 对新型细胞类型和策略的持续研究可能会优化细胞疗法.